← Oncology Approval Tracker

FDA DECISION ·

Lupron Depot

leuprolide acetate · AbbVie

FDA approvalNew or expanded indicationProstate cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Treatment of advanced prostate cancer. FDA removed the palliative qualifier from the previously labeled advanced-prostate-cancer indication.

LAMPGEN ANALYSIS

Why it matters

The revised indication changes the purpose wording for the existing advanced disease population.

What research teams should watch

Use the current label wording in protocols and keep the specific depot strength and interval explicit.

PRIMARY RECORDS

Sources